Cognitive impairment is associated with subcortical magnetic resonance imaging grey matter T2 hypointensity in multiple sclerosis

Multiple Sclerosis

Volumn 12, Issue 4, 2006, Pages 437-444

  Brass, S D ^a   Benedict, R H B ^b   Weinstock Guttman, B ^b   Munschauer, F ^b   Bakshi, Rohit ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b JACOBS NEUROLOGICAL INSTITUTE   (United States)

Author keywords

Brain; Cognition; Grey matter; Iron; MRI; Multiple sclerosis

Indexed keywords

IRON;

ADULT; ARTICLE; ATTENTION; BASAL GANGLION; BRAIN ATROPHY; BRAIN FUNCTION; BRAIN REGION; CAUDATE NUCLEUS; CLINICAL ARTICLE; COGNITIVE DEFECT; CONTROLLED STUDY; CORRELATION COEFFICIENT; FEMALE; GLOBUS PALLIDUS; GRAY MATTER; HUMAN; HYPOTHESIS; LEARNING; MALE; MULTIPLE SCLEROSIS; NEUROPSYCHOLOGICAL TEST; NUCLEAR MAGNETIC RESONANCE IMAGING; PUTAMEN; QUANTITATIVE ANALYSIS; REGRESSION ANALYSIS; RELIABILITY; SCORING SYSTEM; SIGNAL DETECTION; THALAMUS; WORKING MEMORY;

ADULT; ATROPHY; BRAIN; COGNITION DISORDERS; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS, CHRONIC PROGRESSIVE; MULTIPLE SCLEROSIS, RELAPSING-REMITTING; SEVERITY OF ILLNESS INDEX;

EID: 33746547762     PISSN: 13524585     EISSN: None     Source Type: Journal    
DOI: 10.1191/135248506ms1301oa     Document Type: Article

References (64)

1. Rao SM, Leo GJ, Bernardin L, Unverzagt F. Cognitive dysfunction in multiple sclerosis. I. Frequency, patterns, and prediction. Neurology 1991; 41: 685-91.
2. Benedict RH, Carone DA, Bakshi R. Correlating brain atrophy with cognitive dysfunction, mood disturbances, and personality disorder in multiple sclerosis. J Neuroimaging 2004; 14: 36S-4SS.
3. Rao SM. Cognitive function in patients with MS: impairment and treatment. Int J MS Care 2004; 6: 9-22.
4. Arnett PA, Rao SM, Bernardin L, Grafman J, Yetkin FZ, Lobeck L. Relationship between frontal lobe lesions and Wisconsin Card Sorting Test performance in patients with multiple sclerosis. Neurology 1994; 44: 420-25.
5. Rao SM, Leo GJ, Haughton VM, St. Aubin-Faubert P, Bernardin L. Correlation of magnetic resonance imaging with neuropsychological testing in multiple sclerosis. Neurology 1989; 39: 161-66.
6. Swirsky-Sacchetti T, Mitchell. DR. Seward J, Gonzales C, Lublin F, Knobler R et al. Neuropsychological and structural brain lesions in multiple sclerosis: a regional analysis. Neurology 1992; 42: 1291-95.
7. Comi E, Rovaris M, Falautano M, Suntuccio G, Martinelli V, Rocca M et al. A multiparametric MRI study of frontal lobe dementia in multiple sclerosis. J Neurol Sci 1999; 171: 135-44.
8. Camp SJ, Stevenson VL, Thompson AJ, Miller DH, Borras C, Auriacombe S et al. Cognitive function in primary progressive and transitional progressive multiple sclerosis: a controlled study with MRI correlates. Brain 1999; 122: 1341-48.
9. Foong J, Rozewicz L, Quaghebeur G, Davie CA, Kartsounis LD, Thompson AJ et al. Executive function in multiple sclerosis. The role of frontal lobe pathology. Brain 1997; 120: 15-26.
10. Hohol MJ, Guttmann CR, Orav J, Mackin GA, Kikinis R, Khoury SJ et al. Serial neuropsychological assessment and magnetic resonance imaging analysis in multiple sclerosis: Arch Neurol 1997; 54: 1018-25.
11. Litvan I, Grafman J, Vendrell P, Martinez JM. Slowed information processing in multiple sclerosis. Arch Neurol 1988; 45: 281-85.
12. Sperling RA, Guttmann CR, Hohol MJ, Warfield SK, Jakab M, Parente M et al. Regional magnetic resonance imaging lesion burden and cognitive function in multiple sclerosis: a longitudinal study. Arch Neurol 2001; 58: 115-21.
13. Zivadinov R, Sepcic J, Nasuelli D, De Masi R, Bragadin LM, Tommasi MA et al. A longitudinal study of brain atrophy and cognitive disturbances in the early phase of relapsing-remitting multiple sclerosis. J Neurol Neurosurg Psychiatry 2001; 20: 773-80.
14. Rovaris M, Filippi M. MRI correlates of cognitive dysfunction in multiple sclerosis patients. J Neurol Virol 2000; 6: 172-75.
15. Christodoulou C, Krupp LB, Liang Z, Huang W, Melville P, Roque C et al. Cognitive performance and MR markers of cerebral injury in cognitively impaired MS patients. Neurology 2003; 60: 1793-98.
16. Bermel RA, Bakshi R, Tjoa CW, Pull SR, Jacobs L. Bicaudate ratio as a magnetic resonance imaging marker of brain atrophy in multiple sclerosis. Arch Neurol 2002; 59: 275-80.
17. Benedict RH, Weinstock-Guttman B, Fishman I, Sharma J, Tjoa CW, Bakshi R. Prediction of neuropsychological impairment in multiple sclerosis: comparison of conventional magnetic resonance imaging measures of atrophy and lesion burden. Arch Neurol 2004; 61: 226-30.
18. Bakshi R, Benedict RH, Bermel RA, Caruthers SD, Puli SR, Tjoa CW et al. T2 hypointensity in the deep gray matter of patients with multiple sclerosis: a quantitative magnetic resonance imaging study. Arch Neurol 2002; 59: 62-68.
19. Bakshi R, Dmochowski J, Shaikh ZA, Jacobs L. Gray matter T2 hypointensity is related to plaques and atrophy in the brains of multiple sclerosis patients. J Neurol Sci 2001; 185: 19-26.
20. Zhang Y, Metz LM, Zabad R, Lauzon LM, Wei X, Frayne R et al. T2 hypointensity at 3T correlates with Expanded Disability Status Scale in multiple sclerosis. Proceeding of the 13th annual meeting of the International Society for Magnetic Resonance in Medicine, Miami Beach, USA 7-13 May, 2005.
21. Drayer BP, Burger P, Hurwitz B, Dawson D, Cain J. Reduced signal intensity on MR images of the thalamus and putamen in multiple sclerosis: increased iron content? AJR Am J Roentgenol 1987; 149: 357-63.
22. Bermel RA, Puli SR, Rudick RA, Weinstock-Guttman B, Fisher E. Munschauer FE et al. Prediction of longitudinal brain atrophy in multiple sclerosis by gray matter magnetic resonance imaging T2 hypointensity. Arch Neurol 2005; 62: 1371-76.
23. McDonald WI, Compston A, Edan G, Goodkin D, Hartung HP, Lublin FD et al. Recommended diagnostic criteria for multiple sclerosis: guidelines from the international panel on the diagnosis of multiple sclerosis. Ann Neurol 2001; 50: 121-27.
24. Lublin FD, Reingold SC. Defining the clinical course of multiple sclerosis: results of an international survey. National Multiple Sclerosis Society (USA) Advisory Committee on Clinical Trials of New Agents in Multiple Sclerosis. Neurology 1996; 46: 907-11.
25. Kurtze JF. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 1983; 33: 1444-52.
26. Sharma J, Sanfilipo MP, Benedict RHB, Weinstock-Guttman B, Munschauer FE, Bakshi R. Whole brain atrophy in multiple sclerosis measured by automated versus semiautomated MR imaging segmentation. AJNR Am J Neuroradiol 2004; 25: 985-96.
27. Tjoa CW, Benedict RHB, Weinstock-Guttman B, Fabiano AJ, Bakshi R. MRI T2 hypointensity of the dentate nucleus is related to ambulatory impairment in multiple sclerosis. J Neurol Sci 2005; 234: 17-24.
28. Sanfilipo MP, Benedict RH, Zivadinov R, Bakshi R. Correction for intracranial volume in analysis of whole brain atrophy in multiple sclerosis: the proportion vs. residual method. Neuroimage 2004; 22: 1732-43.
29. Bastianello S, Bozzao A, Paolillo A, Giugni E, Gasperini C, Koudriavtseva T et al. Fast spin-echo and fast fluid-attenuated inversion-recovery versus conventional spin-echo sequences for MR quantification of multiple sclerosis lesions. AJNR Am J Neuroradiol 1997; 18: 699-704.
30. Bakshi R, Ariyaratana S, Benedict RHB, Jacobs L. Fluid-attenuated inversion recovery magnetic resonance imaging detects cortical and juxtacortical multiple sclerosis lesions. Arch Neurol 2001; 58: 742-48.
31. Bermel RA, Sharma J, Tjoa CW, Puli SR, Bakshi R. A semiautomated measure of whole-brain atrophy in multiple sclerosis. J Neurol Sci 2003; 208: 57-65.
32. Benedict RHB, Fischer JS, Archibald CJ. Minimal neuropsychological assessment of MS patient: a consensus approach. Clin Neuropsychol 2002; 16: 381-97.
33. Delis DC, Kramer JH, Kaplan E, Ober BA. California Verbal Learning Test manual: Second Edition, Adult Version. Psychological Corporation, 2000.
34. Benedict RHB. The Brief Visuospatial Memory Test Revised (BVMT-R). Psychosocial Assessment Resources Inc., 1997.
35. Gronwall DMA. The Paced Auditory Serial Addition Test (PASAT). Paced auditory serial addition task: a measure of recovery from concussion. Percept Mot Skills 1977; 44: 367-73.
36. Smith A. The Symbol Digit Modalities Test (SDMT) Symbol Digit Modalities Test: Manual. Western Psychological Services, 1982.
37. Benton AL, Sivan AB, Hamsher K, Varney NR, Spreen O. Contributions to neuropsychological assessment. Oxford University Press, 1994.
38. Benton AL, Hamsher K. Multilingual Aphasia Examination. AJA Associates, 1989.
39. Beck AT, Steer RA, Brown GK. BDI - Fast Screen for Medical Patients: Manual. Psychological Corporation, 2000.
40. Rao SM, Glatt S, Hammeke TA, McQuillen MP, Khatri BO, Rhodes AM et al. Chronic progressive multiple sclerosis. Relationship between cerebral ventricular size and the neuropsychological impairment. Arch Neurol 1985; 42: 678-82.
41. Alexander GE, de Long M, Strick PL. Parallel organization of functionally segregated circuits linking basal ganglia and cortex. Ann Rev Neurosci 1986; 9: 357-81.
42. Middleton FA, Strick PL. Basal ganglia output and cognition: evidence from anatomical, behavioral, and clinical studies. Brain Cogn 2000; 42: 183-2000.
43. Fuh JL, Wang SJ. Caudate hemorrhage: clinical features, neuropsychological assessments and radiological findings. Clin Neurol Neurosurg 1995; 4: 296-99.
44. Jahanshahi M, Rowe J, Saleem T, Brown RG, Limousin-Dowsey P, Rothwell JC et al. Striatal contribution to cognition: working memory and executive function in Parkinson's disease before and unilateral posteroventral pallidotomy. J Cogn Neurosci 2002; 14: 298-310.
45. Fabiano AJ, Sharma J, Weinstock-Guttman B, Munschauer FE 3rd, Benedict RH, Zivadinov R et al. Thalamic involvement in multiple sclerosis: a diffusion-weighted magnetic resonance imaging study. J Neuroimaging 2003; 13: 307-14.
46. Inglese M, Liu S, Babb JS, Mannon LJ, Grossman RI, Gonen O. Three-dimensional proton spectroscopy of deep gray matter nuclei in relapsing-remitting MS. Neurology 2004; 63: 170-72.
47. Cifelli A, Arridge M, Jezzard P, Esiri MM, Palace J, Matthews PM. Thalamic neurodegeneration in multiple sclerosis. Ann Neurol 2002; 52: 650-53.
48. Bermel RA, Innus MD, Tjoa CW, Bakshi R. Selective caudate atrophy in multiple sclerosis: a 3D MRI parcellation study. Neuroreport 2003; 14: 335-39.
49. Rocca MA, Gallo A, Colombo B, Falini A, Scotti G, Comi G et al. Functional magnetic resonance imaging correlates of fatigue in multiple sclerosis. Neuroimage 2002; 15: 559-67.
50. Roelcke U, Kappos L, Lechner-Scott J, Brunnschweiler H, Huber S, Ammann W et al. Reduced glucose metabolism in the frontal cortex and basal ganglia of multiple sclerosis patient with fatigue: a 18F-fluorodeoxyglucose positron emission tomography study. Neurology 1997; 48: 1566-71.
51. Blinkenberg M, Rune K, Jensen CV, Ravnborg M, Kyllingsbaek S, Holm S et al. Cortical cerebral metabolism correlates with MRI lesion load and cognitive dysfunction in MS. Neurology 2000; 54: 558-64.
52. Schenck JF, Zimmerman EA. High-field magnetic resonance imaging of brain iron: birth of a biomarker? NMR Biomed 2004; 17: 433-45.
53. Gutteridge JMC. Iron and oxygen radicals in brain. Ann Neurol 1992; 32: 16-21.
54. Richardson DR. Novel chelators for central nervous system disorders that involve alterations in the metabolism of iron and other metal ions. Ann NY Acad Sci 2004; 1012: 326-41.
55. Levine SM, Chakrabarty A. The role of iron in the pathogenesis of experimental allergic encephalomyelitis and multiple sclerosis. Ann NY Acad Sci 2004; 1012: 252-66.
56. Broom KA, Anthony DC, Blamire AM, Waters S, Styles P, Perry VH et al. MRI reveals that early changes in cerebral blood volume precede blood-brain barrier breakdown and overt pathology in MS-like lesions in rat brain. J Cereb Blood Flow Metab 2005; 25: 204-16.
57. Hahn EL. Spin echoes. Phys Rev 1950; 80: 580-94.
58. Inglese M, Ge Y, Jensen J, Helpern J, Herbert J, Grossman RI. Iron accumulation in the deep gray matter of patients with MS measured by magnetic field correlation (abstract). Neurology 2005; 64 (Supp1): A236.
59. Bermel RA, Bakshi R. The measurement and clinical relevance of brain atrophy in multiple sclerosis. Lancet Neurol 2006; 5: 158-70.
60. Bakshi R, Minagar A, Jaisani Z, Wolinsky JS. Imaging of multiple sclerosis: role in neurotherapeutics. NeuroRx 2005; 2: 277-303.
61. Narayana PA. Magnetic resonance spectroscopy in the monitoring of multiple sclerosis. J Neuroimaging 2005; 15 (Suppl 4): s46-s57.
62. Horsfield MA. Magnetization transfer imaging in mutiple sclerosis. J Neuroimaging 2005; 15 (Suppl 4): s58-s67.
63. Goldberg-Zimring D, Mewes AUJ, Maddah M, Warfield SK. Diffusion tensor magnetic resonance imaging in multiple sclerosis. J Neuroimaging 2005; 15 (Suppl 4): s68-s81.
64. Deloire MS, Salort E, Bonnet M, Arimone Y, Boudineau. M, Amieva H et al. Cognitive impairment as a marker of diffuse brain abnormalities in early relapsing remitting multiple sclerosis. J Neurol Neurosurg Psychiatry 2005; 76: 519-26.